These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

184 related items for PubMed ID: 30887140

  • 1. Highly Soluble Glimepiride and Irbesartan Co-amorphous Formulation with Potential Application in Combination Therapy.
    Cruz-Angeles J, Videa M, Martínez LM.
    AAPS PharmSciTech; 2019 Mar 18; 20(4):144. PubMed ID: 30887140
    [Abstract] [Full Text] [Related]

  • 2. Characterization and therapeutic efficacy evaluation of glimepiride and L-arginine co-amorphous formulation prepared by supercritical antisolvent process: Influence of molar ratio and preparation methods.
    Park H, Jin Seo H, Hong SH, Ha ES, Lee S, Kim JS, Baek IH, Kim MS, Hwang SJ.
    Int J Pharm; 2020 May 15; 581():119232. PubMed ID: 32240805
    [Abstract] [Full Text] [Related]

  • 3. Investigation of the dissolution rate and oral bioavailability of atenolol-irbesartan co-amorphous systems.
    Song J, Bao R, Lin M, Li W, Zhao P, Liu X, Fu Q.
    Int J Pharm; 2024 Nov 15; 665():124704. PubMed ID: 39312985
    [Abstract] [Full Text] [Related]

  • 4. Determination of the interaction between glimepiride and hyperbranched polymers in solid dispersions.
    Pahovnik D, Reven S, Grdadolnik J, Borštnar R, Mavri J, Zagar E.
    J Pharm Sci; 2011 Nov 15; 100(11):4700-9. PubMed ID: 21656768
    [Abstract] [Full Text] [Related]

  • 5. A discriminating dissolution method for glimepiride polymorphs.
    Bonfilio R, Pires SA, Ferreira LM, de Almeida AE, Doriguetto AC, de Araújo MB, Salgado HR.
    J Pharm Sci; 2012 Feb 15; 101(2):794-804. PubMed ID: 22052673
    [Abstract] [Full Text] [Related]

  • 6. Hyperbranched poly(esteramides) as solubility enhancers for poorly water-soluble drug glimepiride.
    Reven S, Grdadolnik J, Kristl J, Zagar E.
    Int J Pharm; 2010 Aug 30; 396(1-2):119-26. PubMed ID: 20600725
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Preparation and characterization of spray-dried co-amorphous drug-amino acid salts.
    Jensen KT, Blaabjerg LI, Lenz E, Bohr A, Grohganz H, Kleinebudde P, Rades T, Löbmann K.
    J Pharm Pharmacol; 2016 May 30; 68(5):615-24. PubMed ID: 26245703
    [Abstract] [Full Text] [Related]

  • 9. Co-Amorphous Simvastatin-Nifedipine with Enhanced Solubility for Possible Use in Combination Therapy of Hypertension and Hypercholesterolemia.
    Martínez-Jiménez C, Cruz-Angeles J, Videa M, Martínez LM.
    Molecules; 2018 Aug 28; 23(9):. PubMed ID: 30154310
    [Abstract] [Full Text] [Related]

  • 10. Amino acids as co-amorphous stabilizers for poorly water soluble drugs--Part 1: preparation, stability and dissolution enhancement.
    Löbmann K, Grohganz H, Laitinen R, Strachan C, Rades T.
    Eur J Pharm Biopharm; 2013 Nov 28; 85(3 Pt B):873-81. PubMed ID: 23537574
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Preparation and characterization of co-amorphous Ritonavir-Indomethacin systems by solvent evaporation technique: improved dissolution behavior and physical stability without evidence of intermolecular interactions.
    Dengale SJ, Ranjan OP, Hussen SS, Krishna BS, Musmade PB, Gautham Shenoy G, Bhat K.
    Eur J Pharm Sci; 2014 Oct 01; 62():57-64. PubMed ID: 24878386
    [Abstract] [Full Text] [Related]

  • 14. A comparison of spray drying and milling in the production of amorphous dispersions of sulfathiazole/polyvinylpyrrolidone and sulfadimidine/polyvinylpyrrolidone.
    Caron V, Tajber L, Corrigan OI, Healy AM.
    Mol Pharm; 2011 Apr 04; 8(2):532-42. PubMed ID: 21323367
    [Abstract] [Full Text] [Related]

  • 15. Amino acids as co-amorphous excipients for tackling the poor aqueous solubility of valsartan.
    Huang Y, Zhang Q, Wang JR, Lin KL, Mei X.
    Pharm Dev Technol; 2017 Feb 04; 22(1):69-76. PubMed ID: 27050301
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Study of glimepiride-b-cyclodextrin complex.
    Moyano JR, Ventriglia T, Ginés JM, Muñoz F, Rabasco AM.
    Boll Chim Farm; 2003 Nov 04; 142(9):390-5. PubMed ID: 14971307
    [Abstract] [Full Text] [Related]

  • 18. Characterization of Solid Dispersion of Itraconazole Prepared by Solubilization in Concentrated Aqueous Solutions of Weak Organic Acids and Drying.
    Parikh T, Sandhu HK, Talele TT, Serajuddin AT.
    Pharm Res; 2016 Jun 04; 33(6):1456-71. PubMed ID: 26951566
    [Abstract] [Full Text] [Related]

  • 19. Study of the amorphous glibenclamide drug: analysis of the molecular dynamics of quenched and cryomilled material.
    Wojnarowska Z, Grzybowska K, Adrjanowicz K, Kaminski K, Paluch M, Hawelek L, Wrzalik R, Dulski M, Sawicki W, Mazgalski J, Tukalska A, Bieg T.
    Mol Pharm; 2010 Oct 04; 7(5):1692-707. PubMed ID: 20669906
    [Abstract] [Full Text] [Related]

  • 20. Incorporation of Complexation into a Coamorphous System Dramatically Enhances Dissolution and Eliminates Gelation of Amorphous Lurasidone Hydrochloride.
    Heng W, Su M, Cheng H, Shen P, Liang S, Zhang L, Wei Y, Gao Y, Zhang J, Qian S.
    Mol Pharm; 2020 Jan 06; 17(1):84-97. PubMed ID: 31794225
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.